1. Home
  2. IMMP vs INSG Comparison

IMMP vs INSG Comparison

Compare IMMP & INSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • INSG
  • Stock Information
  • Founded
  • IMMP 1987
  • INSG 1996
  • Country
  • IMMP Australia
  • INSG United States
  • Employees
  • IMMP N/A
  • INSG N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • INSG Telecommunications Equipment
  • Sector
  • IMMP Health Care
  • INSG Telecommunications
  • Exchange
  • IMMP Nasdaq
  • INSG Nasdaq
  • Market Cap
  • IMMP 264.7M
  • INSG 230.9M
  • IPO Year
  • IMMP N/A
  • INSG 2000
  • Fundamental
  • Price
  • IMMP $2.05
  • INSG $11.88
  • Analyst Decision
  • IMMP Buy
  • INSG Buy
  • Analyst Count
  • IMMP 2
  • INSG 3
  • Target Price
  • IMMP $8.50
  • INSG $16.00
  • AVG Volume (30 Days)
  • IMMP 106.2K
  • INSG 298.0K
  • Earning Date
  • IMMP 11-26-2024
  • INSG 11-12-2024
  • Dividend Yield
  • IMMP N/A
  • INSG N/A
  • EPS Growth
  • IMMP N/A
  • INSG N/A
  • EPS
  • IMMP N/A
  • INSG N/A
  • Revenue
  • IMMP $2,563,302.00
  • INSG $207,478,000.00
  • Revenue This Year
  • IMMP N/A
  • INSG $13.25
  • Revenue Next Year
  • IMMP $10.84
  • INSG $5.55
  • P/E Ratio
  • IMMP N/A
  • INSG N/A
  • Revenue Growth
  • IMMP 9.59
  • INSG 0.79
  • 52 Week Low
  • IMMP $1.58
  • INSG $1.60
  • 52 Week High
  • IMMP $3.34
  • INSG $20.67
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 55.82
  • INSG 34.37
  • Support Level
  • IMMP $1.85
  • INSG $10.52
  • Resistance Level
  • IMMP $2.06
  • INSG $19.75
  • Average True Range (ATR)
  • IMMP 0.10
  • INSG 1.53
  • MACD
  • IMMP 0.03
  • INSG -0.76
  • Stochastic Oscillator
  • IMMP 70.89
  • INSG 14.18

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About INSG Inseego Corp.

Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).

Share on Social Networks: